Related Experiment Video
Updated: Jan 17, 2026

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
Published on: May 25, 2022
Circular RNA circFTO promotes pressure overload-induced cardiac hypertrophy by encoding a novel protein FTO-36aa
Rong-Rong Zhu1,2, Qi-Rong Xu3, Zhong-Yong Liu2
1Clinical School of Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
Background:
Pathological cardiac hypertrophy leading to ventricular remodeling poses a significant threat to human health. Circular RNAs (circRNAs) play a potential role in the dysregulation of cardiac hypertrophy, and recent evidence highlights their translational ability in various diseases. However, it is not clear whether circRNAs play a protein-coding role in myocardial hypertrophy and ventricular remodeling. This study aimed to investigate the role of circRNA derived from the fat mass and obesity-associated (FTO) gene (circFTO), a translatable circRNA, and the circFTO-encoded a 36 amino acid protein (FTO-36aa) in the pathogenesis of myocardial hypertrophy.
Methods:
A transverse aortic constriction (TAC)-induced hypertrophy mouse model was established. The heart function of the C57BL/6 mice was evaluated. Myocardial structure injury and fibrosis were analyzed by hematoxylin and eosin (H&E) staining and Masson staining. CircRNA microarray assays were used to screen the dysregulated circRNAs. The recombinant adenovirus-associated virus (AAV) was constructed to overexpress or knockdown FTO protein or circFTO. Mass spectrometry analyses, dual-luciferase reporter assays, and polysome profiling analyses were performed to detect the FTO-36aa.
Results:
The study identified dysregulated circRNAs in sham and TAC models, and found that an upregulated circRNA, circFTO, is generated from the back-splicing of FTO exon 5 and exon 7. The silencing of circFTO by AAV significantly weakened the TAC-induced hypertrophy phenotype. The study also identified a novel protein, FTO-36aa, coded by circFTO, that caused the pro-hypertrophy effect of circFTO. FTO-36aa promoted the ubiquitination-mediated protein degradation of FTO, which suppressed the demethylation of RNA, elevating the global N6-methyladenosine (m6A) methylation. Further, the m6A reader, IGF2BP2, recognized the circFTO/FTO-36aa elevated m6A methylation and increased the messenger RNA (mRNA) stabilities of the m6A methylated hypertrophic genes.
Conclusions:
Overall, this study shed light on the functional importance of alternative splicing-generated circFTO and its coded FTO-36aa during myocardial hypertrophy. The findings provide fundamental insights into the mechanisms of m6A methylation regulation in hypertrophic cardiomyocytes.
Related Concept Videos
Heart Failure II: Pathophysiology
MAPK Signaling Cascades
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Regulation of the Unfolded Protein Response
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

